{"id":"W4319970241","doi":"10.3390/pharmaceutics15020601","title":"Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union","year":2023,"lang":"en","type":"review","venue":"Pharmaceutics","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Canada","funders":"Health Canada; Agencia Española de Medicamentos y Productos Sanitarios; World Health Organization","keywords":"Bioequivalence; European union; Tolerability; Excipient; Pharmacology; Pharmacodynamics; Generic drug; Drug; Clinical trial; Medicine; Equivalence (formal languages); Food and drug administration; Pharmacokinetics; Business; Mathematics; Adverse effect; Internal medicine; International trade","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007322098,0.0005793689,0.0009279674,0.0001833064,0.0003974896,0.00002407375,0.001613561,0.0003310815,0.0001467343],"category_scores_gemma":[0.0001670597,0.0003797306,0.0002933426,0.0006176804,0.0003199058,0.00009434254,0.0003154772,0.001810178,0.0001143893],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002282724,"about_ca_system_score_gemma":0.0004502403,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":7.83854e-7,"about_ca_topic_score_gemma":0.00001639112,"domain_scores_codex":[0.9931731,0.003372337,0.001641561,0.0006045697,0.0004519833,0.0007564845],"domain_scores_gemma":[0.9964756,0.002008804,0.0006339131,0.0006401632,0.0001327084,0.0001087624],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004410622,0.0003352021,0.0000257059,0.01847096,0.0007844102,0.00002601227,0.001783701,0.0000884998,0.00007052795,0.0001336965,0.004692802,0.9735444],"study_design_scores_gemma":[0.001019585,0.00002686922,0.0000372329,0.001259923,0.001276187,0.0000140932,0.000159746,0.00009557668,0.0006640438,0.00004666185,0.9950209,0.0003791943],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001579964,0.9883154,0.000492215,0.0003537619,0.003193058,0.004740301,0.0002497951,0.00008916928,0.002408292],"genre_scores_gemma":[0.0007921982,0.9942281,0.0005125181,0.0006428549,0.0008238681,0.0005707656,0.0002342001,0.0001380862,0.00205747],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9903281,"threshold_uncertainty_score":0.9998655,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4280218919215843,"score_gpt":0.5174462811157179,"score_spread":0.08942438919413359,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}